E2F3

Summary

Gene Symbol: E2F3
Description: E2F transcription factor 3
Alias: E2F-3, transcription factor E2F3
Species: human

Top Publications

  1. ncbi Expression analysis of 6p22 genomic gain in retinoblastoma
    Marija Orlic
    Department of Molecular and Medical Genetics, University of Toronto, Toronto, ON, Canada
    Genes Chromosomes Cancer 45:72-82. 2006
  2. ncbi E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases
    Shweta Tyagi
    Center for Integrative Genomics, University of Lausanne, Genopode, 1015 Lausanne, Switzerland
    Mol Cell 27:107-19. 2007
  3. ncbi Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells
    Yukihiro Akao
    Gifu University, Yanagido, Japan
    Cancer Lett 300:197-204. 2011
  4. ncbi The E2F3-Oncomir-1 axis is activated in Wilms' tumor
    Eric J Kort
    Laboratory of Molecular Epidemiology, Van Andel Research Institute, Grand Rapids, MI 49503, USA
    Cancer Res 68:4034-8. 2008
  5. ncbi Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma
    Corinna Grasemann
    University Children s Hospital of Essen, Universitatsklinikum Essen, D 45122 Essen, Germany
    Oncogene 24:6441-9. 2005
  6. ncbi BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases
    H Wang
    Department of Human Genetics, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania 19102, USA
    Oncogene 15:143-57. 1997
  7. ncbi Gene expression profiles of hepatoma cell line BEL-7402
    Lian Xin Liu
    Department of Surgery, First Clinical College of Harbin Medical University, No 23 Youzheng Street, Nangang District, Harbin 150001, P R China
    Hepatogastroenterology 50:1496-501. 2003
  8. ncbi Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study
    Demetrios A Arvanitis
    Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    Oncol Rep 20:751-60. 2008
  9. ncbi Opposite effects of interleukin-1alpha and transforming growth factor-beta2 induce stage-specific regulation of junctional adhesion molecule-B gene in Sertoli cells
    Yang Wang
    Division of Endocrinology, School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong
    Endocrinology 150:2404-12. 2009
  10. ncbi The molecular and functional characterization of E2F-5 transcription factor
    Y N Vaishnav
    Virology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India
    Biochem Biophys Res Commun 242:586-92. 1998

Research Grants

  1. Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
    Michele Pagano; Fiscal Year: 2009
  2. E2F-mediated Control of Vascular Growth and Remodeling
    Bruce Sullenger; Fiscal Year: 2006
  3. E2F3: a suppressor of centrosome amplification
    HAROLD SAAVEDRA; Fiscal Year: 2007
  4. Tumor Suppressor and Oncogenic Pathways in the Placenta
    Lizhao Wu; Fiscal Year: 2007
  5. Retinoblastoma during placental & embryonic development
    Michael Weinstein; Fiscal Year: 2006
  6. E2F3 and embryonic development
    Gustavo Leone; Fiscal Year: 2007
  7. Dissecting E2f3's role in tumorigenesis
    JACQUELINE LEES; Fiscal Year: 2007
  8. Dissecting E2f3's role in tumorigenesis
    JACQUELINE LEES; Fiscal Year: 2009
  9. Dissecting E2f3's role in tumorigenesis
    Jacqueline A Lees; Fiscal Year: 2010
  10. E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION
    Gustavo Leone; Fiscal Year: 2005

Scientific Experts

Detail Information

Publications139 found, 100 shown here

  1. ncbi Expression analysis of 6p22 genomic gain in retinoblastoma
    Marija Orlic
    Department of Molecular and Medical Genetics, University of Toronto, Toronto, ON, Canada
    Genes Chromosomes Cancer 45:72-82. 2006
    ..6 Mb minimal region of gain at 6p22 (DEK, AOF1, TPMT, NHLRC1, KIF13A, and NUP153), and E2F3 is 2 Mb away from the minimal region of gain on 6p22...
  2. ncbi E2F activation of S phase promoters via association with HCF-1 and the MLL family of histone H3K4 methyltransferases
    Shweta Tyagi
    Center for Integrative Genomics, University of Lausanne, Genopode, 1015 Lausanne, Switzerland
    Mol Cell 27:107-19. 2007
    ..These results suggest that HCF-1 induces cell-cycle-specific transcriptional activation by E2F proteins to promote cell proliferation...
  3. ncbi Dysregulation of microRNA-34a expression causes drug-resistance to 5-FU in human colon cancer DLD-1 cells
    Yukihiro Akao
    Gifu University, Yanagido, Japan
    Cancer Lett 300:197-204. 2011
    ..growth, as in the parental cells, and attenuated the resistance to 5-FU through the down-regulation of Sirt1 and E2F3. Moreover, the silencing of Sirt1 significantly canceled the resistance to 5-FU in the 5-FU-resistant cells...
  4. ncbi The E2F3-Oncomir-1 axis is activated in Wilms' tumor
    Eric J Kort
    Laboratory of Molecular Epidemiology, Van Andel Research Institute, Grand Rapids, MI 49503, USA
    Cancer Res 68:4034-8. 2008
    ..Previous in vitro studies showed that it is transcriptionally regulated by the transcription factor E2F3. In this report, we combine expression profiling of both mRNA and miRNAs in Wilms' tumor (WT) samples to ..
  5. ncbi Gains and overexpression identify DEK and E2F3 as targets of chromosome 6p gains in retinoblastoma
    Corinna Grasemann
    University Children s Hospital of Essen, Universitatsklinikum Essen, D 45122 Essen, Germany
    Oncogene 24:6441-9. 2005
    ..The remaining 20 (26%) samples showed gains only at some loci, most often including E2F3 and DEK in 6p22.3...
  6. ncbi BRCA1 proteins are transported to the nucleus in the absence of serum and splice variants BRCA1a, BRCA1b are tyrosine phosphoproteins that associate with E2F, cyclins and cyclin dependent kinases
    H Wang
    Department of Human Genetics, Allegheny University of the Health Sciences, Philadelphia, Pennsylvania 19102, USA
    Oncogene 15:143-57. 1997
    ....
  7. ncbi Gene expression profiles of hepatoma cell line BEL-7402
    Lian Xin Liu
    Department of Surgery, First Clinical College of Harbin Medical University, No 23 Youzheng Street, Nangang District, Harbin 150001, P R China
    Hepatogastroenterology 50:1496-501. 2003
    ..To investigate the gene expression of cancer related genes in hepatoma cell line BEL-7402 through the usage of Atlas Human Cancer Array with 588 well-characterized human genes related with cancer biology...
  8. ncbi Deregulation of the G1/S phase transition in cancer and squamous intraepithelial lesions of the uterine cervix: a case control study
    Demetrios A Arvanitis
    Molecular Biology Division, Biomedical Research Foundation, Academy of Athens, Athens, Greece
    Oncol Rep 20:751-60. 2008
    ..were found to be upregulated only in tumours, RBL2, E2F2, CDK6, CCNE1 and MYC; eight in tumours and HSILs, E2F1, E2F3, E2F5, CCND1, CDK2, CDKN1B, PCNA and POLA, and five in tumours, HSILs and LSILs, TP53, E2F4, CDKN1A, CDKN2A and ..
  9. ncbi Opposite effects of interleukin-1alpha and transforming growth factor-beta2 induce stage-specific regulation of junctional adhesion molecule-B gene in Sertoli cells
    Yang Wang
    Division of Endocrinology, School of Biological Sciences, The University of Hong Kong, Pokfulam, Hong Kong
    Endocrinology 150:2404-12. 2009
    ..transcription factor Elk-1 (Elk1), neuron-restrictive silencer factor (NRSF), and E2F transcription factor 3 (E2F3) to various cis-acting elements including TG interacting factor (TGIF), Elk-1, NRSF, and proximal Sp1 (pSp1) + E2F ..
  10. ncbi The molecular and functional characterization of E2F-5 transcription factor
    Y N Vaishnav
    Virology Group, International Centre for Genetic Engineering and Biotechnology, New Delhi, India
    Biochem Biophys Res Commun 242:586-92. 1998
    ..We have also demonstrated the presence of a strong transactivation domain at the carboxy terminus (273-346 amino acid residues) of E2F-5 protein...
  11. ncbi Calpain3 is expressed in a proteolitically active form in papillomavirus-associated urothelial tumors of the urinary bladder in cattle
    Sante Roperto
    Department of Pathology and Animal Health, Division of Infectious Diseases, Naples University Federico II, Naples, Italy
    PLoS ONE 5:e10299. 2010
    ..So far the link between calpain3 and tumors comes from in vitro studies. The objective of this study was to describe Capn3 activation in naturally occurring urothelial tumors of the urinary bladder in cattle...
  12. ncbi Transcriptional regulation of fibrillin-2 gene by E2F family members in chondrocyte differentiation
    Takuya Yanagino
    Department of Biological Science and Technology, The University of Tokushima Graduate School, Tokushima, Japan
    J Cell Biochem 106:580-8. 2009
    ..The increase in promoter activity by E2F1 was completely suppressed by the coexpression of E2F4. E2F2 and E2F3 had positive effects on the promoter activity...
  13. ncbi Novel 6p rearrangements and recurrent translocation breakpoints in retinoblastoma cell lines identified by spectral karyotyping and mBAND analyses
    Jana Paderova
    Department of Applied Molecular Oncology, Ontario Cancer Institute, Princess Maragaret Hospital, 610 University Avenue, Toronto, Ontario, Canada M5G 2M9
    Cancer Genet Cytogenet 179:102-11. 2007
    ..The minimal region of gain maps to chromosome band 6p22. Two genes, DEK and E2F3, are implicated as candidate oncogenes...
  14. ncbi Translating DNA damage into cancer cell death-A roadmap for E2F1 apoptotic signalling and opportunities for new drug combinations to overcome chemoresistance
    David Engelmann
    Department of Vectorology and Experimental Gene Therapy, Biomedical Research Center, University of Rostock Medical School, 18057 Rostock, Germany
    Drug Resist Updat 13:119-31. 2010
    ..Notably, the lately uncovered role of pRB and E2F3 in triggering E2F1-dependent apoptosis through chemotherapy gains our understanding of the DNA damage response in ..
  15. ncbi GCN5: a supervisor in all-inclusive control of vertebrate cell cycle progression through transcription regulation of various cell cycle-related genes
    Hidehiko Kikuchi
    Department of Life Science, Frontier Science Research Center, Miyazaki Medical College, University of Miyazaki, 5200, Kihara, Kiyotake, Miyazaki 889 1692, Japan
    Gene 347:83-97. 2005
    ....
  16. ncbi Enhanced proliferation of monolayer cultures of embryonic stem (ES) cell-derived cardiomyocytes following acute loss of retinoblastoma
    Satoshi Yamanaka
    Laboratory of Cardiovascular Science, National Institute on Aging, Baltimore, Maryland, USA
    PLoS ONE 3:e3896. 2008
    ..Cardiomyocyte (CM) cell cycle analysis has been impeded because of a reliance on primary neonatal cultures of poorly proliferating cells or chronic transgenic animal models with innate compensatory mechanisms...
  17. ncbi Expression of the E2F family of transcription factors and its clinical relevance in ovarian cancer
    Daniel Reimer
    Department of Obstetrics and Gynecology, Medical University Innsbruck, Anichstrasse 35, A 6020 Innsbruck
    Ann N Y Acad Sci 1091:270-81. 2006
    ..Taken together, these data suggest that the proliferation-promoting E2F transcription factors E2F-1 and especially E2F-2 play a pivotal role in tumor biology of ovarian cancer and may be candidates for specific therapeutic targets...
  18. ncbi Lack of CCAAT enhancer binding protein beta (C/EBPbeta) in uterine epithelial cells impairs estrogen-induced DNA replication, induces DNA damage response pathways, and promotes apoptosis
    Cyril Ramathal
    Department of Cell and Developmental Biology, and Center for Research in Reproduction and Infertility, University of Illinois at Urbana Champaign, Urbana, IL 61801, USA
    Mol Cell Biol 30:1607-19. 2010
    ..This cell cycle arrest was accompanied by markedly reduced levels of expression of E2F3, an E2F family member, and a lack of nuclear localization of cyclin E, a critical regulator of cdk2...
  19. ncbi Human proximal tubular cell responses to angiotensin II analyzed using DNA microarray
    Branko Braam
    Nephrology Section, and Tulane Environmental Astrobiology Center, New Orleans, LA, USA
    Eur J Pharmacol 464:87-94. 2003
    ..observed in genes of the hepatocyte nuclear factor 3 family (NHF3; HNF3A, HNF3B and HNF3G), in the E2F genes (E2F1, E2F3) and the interferon regulatory factors IRF1 and IRF5...
  20. ncbi The DP-1 transcription factor is required for keratinocyte growth and epidermal stratification
    Wing Y Chang
    Department of Physiology and Pharmacology, University of Western Ontario, London, Ontario N6A 5C1, Canada
    J Biol Chem 279:51343-53. 2004
    ..We conclude that DP-1 activity is required for normal epidermal morphogenesis and ectoderm-to-epidermis transition...
  21. ncbi Yin yang 1 modulates taxane response in epithelial ovarian cancer
    Noriomi Matsumura
    Division of Gynecologic Oncology, Department of Obstetrics and Gynecology, Duke University Medical Center, Durham, NC 27708, USA
    Mol Cancer Res 7:210-20. 2009
    ..Clustering of microarray data for these genes revealed that high YY1/E2F3 activity positively correlates with survival of patients treated with the microtubule-stabilizing drug paclitaxel...
  22. ncbi Selective requirements for E2f3 in the development and tumorigenicity of Rb-deficient chimeric tissues
    Tiziana Parisi
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
    Mol Cell Biol 27:2283-93. 2007
    ..In this study, we isolated Rb; E2f3 mutant embryonic stem cells and generated Rb(-/-); E2f3(-/-) chimeric mice, thus bypassing the lethality of the Rb(-..
  23. ncbi OncomiRs: the discovery and progress of microRNAs in cancers
    William C S Cho
    Department of Clinical Oncology, Queen Elizabeth Hospital, Room 1305, 13 F, Block R, 30 Gascoigne Road, Kowloon, Hong Kong SAR, PR China
    Mol Cancer 6:60. 2007
    ..miR-34a acts as a suppressor of neuroblastoma tumorigenesis by targeting the mRNA encoding E2F3 and reducing E2F3 protein levels...
  24. ncbi A role for E2F activities in determining the fate of Myc-induced lymphomagenesis
    Rachel E Rempel
    Duke Institute for Genome Sciences and Policy, Department of Molecular Genetics and Microbiology, Duke University Medical Center, Durham, North Carolina, United States of America
    PLoS Genet 5:e1000640. 2009
    ..Whereas the absence of E2F1 and E2F3 function has no impact on Myc-mediated tumor development, the absence of E2F2 substantially accelerates the time of ..
  25. ncbi Genomic profiling of microRNAs and messenger RNAs reveals hormonal regulation in microRNA expression in human endometrium
    Satu Kuokkanen
    Department of Obstetrics and Gynecology and Women s Health, Cooperative Center for the Study of Reproduction and Infertility Research, Albert Einstein College of Medicine, Bronx, NY 10461, USA
    Biol Reprod 82:791-801. 2010
    ..the transcript abundance of predicted targets, including cyclins and cyclin-dependent kinases, as well as E2F3 (a known target of MIR210), was decreased...
  26. ncbi E2F-4 switches from p130 to p107 and pRB in response to cell cycle reentry
    K Moberg
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, 02139, USA
    Mol Cell Biol 16:1436-49. 1996
    ..Despite this, a considerable amount of E2F-4 exists as free E2F. In G1 cells, this accounts for almost all of the free activity. Once the cells enter S phase, free E2F is composed of an equal mixture of E2F-4 and E2F-1...
  27. ncbi Identification of nuclear localization signal that governs nuclear import of BRD7 and its essential roles in inhibiting cell cycle progression
    Ming Zhou
    Cancer Research Institute, Central South University Xiang Ya School of Medicine, 110 Xiang Ya Road, Changsha, Hunan 410078, China
    J Cell Biochem 98:920-30. 2006
    ..some important molecules involved in ras/MEK/ERK and Rb/E2F pathway, and downregulate the promoter activity of E2F3. In the present study, the subcellular localization of BRD7 was investigated...
  28. ncbi Transcription of the MAT2A gene, coding for methionine adenosyltransferase, is up-regulated by E2F and Sp1 at a chromatin level during proliferation of liver cells
    Jose L Rodriguez
    Department of Biochemistry and Molecular Biology, University of Valencia, Spain
    Int J Biochem Cell Biol 39:842-50. 2007
    ..that a putative E2F sequence present in MAT2A promoter binds this factor and ChIP assays confirmed that E2F1, E2F3 and E2F4, as well as the pocket protein p130, are bound to the promoter in quiescent liver...
  29. ncbi E2F regulates DDB2: consequences for DNA repair in Rb-deficient cells
    S Prost
    Queen s Medical Research Institute, University of Edinburgh, Edinburgh, UK
    Oncogene 26:3572-81. 2007
    ..Furthermore, we show that endogenous E2F1 and E2F3 bind to DDB2 promoter and that treatment with E2F1-antisense or E2F1-small interfering RNA (siRNA) decreases DDB2 ..
  30. ncbi Direct binding of apoptosis signal-regulating kinase 1 to retinoblastoma protein: novel links between apoptotic signaling and cell cycle machinery
    Piyali Dasgupta
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, Tampa, Florida 33612, USA
    J Biol Chem 279:38762-9. 2004
    ..immunoprecipitation assays show that in asynchronous cells the p73P1 promoter is occupied predominantly by E2F3; upon tumor necrosis factor (TNF)-alpha stimulation, E2F3 is dissociated from the promoter and replaced by E2F1...
  31. ncbi Cell cycle and transcriptional control of human myeloid leukemic cells by transforming growth factor beta
    X Hu
    Department of Internal Medicine, University of South Florida, and H Lee Moffitt Cancer Center and Research Institute, Tampa 33612, USA
    Leuk Lymphoma 38:235-46. 2000
    ..In summary, TGFbeta1 inhibits growth of human myeloid leukemic cells through multiple pathways, whereas the "cdk inhibitor" p27 is both a positive and negative regulator...
  32. ncbi Molecular characterization of breast cancer with high-resolution oligonucleotide comparative genomic hybridization array
    Fabrice Andre
    Translational Research Unit, UPRES03535, Paris Sud University, Orsay, France
    Clin Cancer Res 15:441-51. 2009
    ..We used high-resolution oligonucleotide comparative genomic hybridization (CGH) arrays and matching gene expression array data to identify dysregulated genes and to classify breast cancers according to gene copy number anomalies...
  33. ncbi Profiling genomic copy number changes in retinoblastoma beyond loss of RB1
    Ella Bowles
    Division of Applied Molecular Oncology, Ontario Cancer Institute Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
    Genes Chromosomes Cancer 46:118-29. 2007
    ..Gene-specific quantitative multiplex polymerase chain reaction of candidate oncogenes at 1q32.1 (KIF14), 6p22 (E2F3 and DEK), and tumor suppressor genes at 16q22 (CDH11) and 17q21 (NGFR) showed the most common gene gains in RB to ..
  34. ncbi [Evaluation of potential target genes of the 6p22.3-amplicon in urinary bladder cancer]
    M Oeggerli
    Institute of Pathology, University of Basel, University Hospital, Basel, Switzerland
    Verh Dtsch Ges Pathol 89:219-24. 2005
    ..The highest amplification rates were observed for the transcription factor E2F3 and the adjacent gene NM_017774, the function of which is not known...
  35. ncbi Adenosine administration accelerates progression of the cell cycle during rat liver regeneration induced by one-third hepatectomy
    Edgar Mendieta-Condado
    Departamento de Biologia Celular, Instituto de Fisiologia Celular, Universidad Nacional Autonoma de Mexico, Ciudad de Mexico, Mexico
    J Pharmacol Exp Ther 331:122-32. 2009
    ..Therefore, these pharmacological adenosine effects suggest a modulating role for the nucleoside on mitogenic events once the liver has been triggered to proliferate...
  36. ncbi Chromatin loading of E2F-MLL complex by cancer-associated coregulator ANCCA via reading a specific histone mark
    Alexey S Revenko
    Department of Biochemistry and Molecular Medicine, School of Medicine, University of California at Davis, Sacramento, CA 95817, USA
    Mol Cell Biol 30:5260-72. 2010
    ..We report here that ANCCA directly interacts with E2F1 to E2F3 and that its N terminus interacts with both the N and C termini of E2F1...
  37. ncbi A lentiviral vector with expression controlled by E2F-1: a potential tool for the study and treatment of proliferative diseases
    Bryan E Strauss
    Viral Vector Group, Laboratory of Genetics and Molecular Cardiology LIM 13, University of Sao Paulo School of Medicine, Brazil
    Biochem Biophys Res Commun 348:1411-8. 2006
    ..We propose that the FE2FLW vector may be a starting point for the development of gene therapy strategies for proliferative diseases, such as cancer or restinosis...
  38. ncbi E2F-5, a new E2F family member that interacts with p130 in vivo
    E M Hijmans
    Division of Molecular Carcinogenesis, Netherlands Cancer Institute, Amsterdam
    Mol Cell Biol 15:3082-9. 1995
    ..E2F-5 resembles the other E2Fs in that it binds to a consensus E2F site in a cooperative fashion with DP-1. By using a specific E2F-5 antiserum, we found that under physiological conditions, E2F-5 interacts preferentially with p130...
  39. ncbi Distinct recruitment of E2F family members to specific E2F-binding sites mediates activation and repression of the E2F1 promoter
    Keigo Araki
    Section of Molecular Craniofacial Embryology, Graduate School, Tokyo Medical and Dental University, 1 5 45, Yushima, Bunkyo ku, Tokyo 113 8549, Japan
    Oncogene 22:7632-41. 2003
    ..revealed that the E2F4/p130 repressor complex specifically binds to the distal E2F-binding site, whereas E2F1 and E2F3 activators preferentially bind to the proximal E2F-binding site...
  40. ncbi Amplification and overexpression of the ID4 gene at 6p22.3 in bladder cancer
    Qiong Wu
    Dept of Urology, Heinrich Heine University, Dusseldorf, Germany
    Mol Cancer 4:16. 2005
    ..3 are prevalent in advanced stage bladder cancer (TCC). Previous studies have identified SOX4, CDKAL, and E2F3 as targets of this amplification and therefore potential oncogenes, but the more telomeric DEK gene too has been ..
  41. ncbi Mutant mouse models reveal the relative roles of E2F1 and E2F3 in vivo
    Jennifer E Cloud
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    Mol Cell Biol 22:2663-72. 2002
    ..Here we use mutant mouse strains to investigate E2F3's role in vivo...
  42. ncbi Unique requirement for Rb/E2F3 in neuronal migration: evidence for cell cycle-independent functions
    Kelly A McClellan
    Department of Cellular and Molecular Medicine, Ottawa Health Research Institute, University of Ottawa, Ottawa, ON, Canada
    Mol Cell Biol 27:4825-43. 2007
    ..We sought to determine the Rb-interacting factors that mediate both the cell cycle and migration defects. E2F1 and E2F3 are likely Rb-interacting candidates that we have shown to be deregulated in the absence of Rb...
  43. ncbi E2F3 is the main target gene of the 6p22 amplicon with high specificity for human bladder cancer
    M Oeggerli
    Department of Molecular Pathology, Institute of Pathology, University of Basel, Basel, Switzerland
    Oncogene 25:6538-43. 2006
    ..Candidate target genes for the 6p22 amplicon include E2F3 and the adjacent gene NM_017774...
  44. ncbi Control of the p53-p21CIP1 Axis by E2f1, E2f2, and E2f3 is essential for G1/S progression and cellular transformation
    Nidhi Sharma
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology, and Medical Genetics, Comprehensive Cancer Center, Ohio State University, Columbus, Ohio 43210, USA
    J Biol Chem 281:36124-31. 2006
    ..Previous work has demonstrated that the targeted inactivation of E2f1, E2f2, and E2f3 results in elevated p21(CIP1) protein levels, loss of E2F target gene expression, and cell cycle arrest at G1/S and ..
  45. ncbi Repression of the Arf tumor suppressor by E2F3 is required for normal cell cycle kinetics
    Aaron Aslanian
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    Genes Dev 18:1413-22. 2004
    ..In wild-type mouse embryonic fibroblasts (MEFs), the Arf promoter is occupied by E2F3 and not other E2F family members...
  46. ncbi E2f1, E2f2, and E2f3 control E2F target expression and cellular proliferation via a p53-dependent negative feedback loop
    Cynthia Timmers
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics, and Comprehensive Cancer Center, The Ohio State University, 410 W 12th Avenue, Columbus, OH 43210, USA
    Mol Cell Biol 27:65-78. 2007
    ..approach, we show that the targeted disruption of the entire E2F activator subclass composed of E2f1, E2f2, and E2f3 in mouse embryonic fibroblasts leads to the activation of p53 and the induction of p53 target genes, including p21(..
  47. ncbi E2F3 plays an essential role in cardiac development and function
    Jennifer C King
    David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139, USA
    Cell Cycle 7:3775-80. 2008
    ..This study shows that E2F3 is essential for normal cardiac development...
  48. ncbi E2f3a and E2f3b make overlapping but different contributions to total E2f3 activity
    P S Danielian
    David H Koch Institute for Integrative Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
    Oncogene 27:6561-70. 2008
    ..b>E2F3 has garnered particular attention because it is amplified in various human tumors...
  49. ncbi Epstein-Barr virus downregulates microRNA 203 through the oncoprotein latent membrane protein 1: a contribution to increased tumor incidence in epithelial cells
    Haibo Yu
    Cancer Research Institute, Central South University, Changsha, Hunan, People s Republic of China
    J Virol 86:3088-99. 2012
    ..EBV-LMP1 mediated the downregulation of miR-203 at the primary transcript level. E2F3 and CCNG1 were identified as target genes of miR-203...
  50. ncbi The SNF2-like helicase HELLS mediates E2F3-dependent transcription and cellular transformation
    Björn von Eyss
    Cancer Research, Max Delbrück Centrum für Molekulare Medizin MDC, Berlin, Germany
    EMBO J 31:972-85. 2012
    ..b>E2F3 is uniquely amplified in specific human tumours where its expression is inversely correlated with the survival of ..
  51. ncbi Pumilio facilitates miRNA regulation of the E2F3 oncogene
    Wayne O Miles
    Massachusetts General Hospital Cancer Center, Laboratory of Molecular Oncology, Harvard Medical School, Charlestown, 02129, USA
    Genes Dev 26:356-68. 2012
    ..The human Pumilio homologs Pum 1 and Pum 2 repress the translation of E2F3 by binding to the E2F3 3' untranslated region (UTR) and also enhance the activity of multiple E2F3 targeting ..
  52. ncbi JNK activation is regulated by E2F and promotes E2F1-induced apoptosis
    Dana Bashari
    The Mina and Everard Goodman Faculty of Life Science, Bar Ilan University, Ramat Gan, Israel
    Cell Signal 23:65-70. 2011
    ..Accordingly, downregulating E2F1and E2F3 inhibits sustained UV-induced JNK phosphorylation and ectopic expression of E2F1 or E2F3 induces JNK ..
  53. ncbi The biochemical basis of CDK phosphorylation-independent regulation of E2F1 by the retinoblastoma protein
    Matthew J Cecchini
    London Regional Cancer Program, University of Western Ontario, London, Ontario, N6A 4L6, Canada
    Biochem J 434:297-308. 2011
    ..and proline residues in the marked box distinguishes E2F1's ability to interact with ppRB from the inability of E2F3 to bind to the 'specific' site in ppRB...
  54. ncbi One hit, two hits, three hits, more? Genomic changes in the development of retinoblastoma
    Timothy W Corson
    Division of Applied Molecular Oncology, Ontario Cancer Institute Princess Margaret Hospital, University Health Network, Toronto, ON, Canada
    Genes Chromosomes Cancer 46:617-34. 2007
    ..candidate oncogenes and tumor suppressor genes within these regions, including the candidates (KIF14, MDM4, MYCN, E2F3, DEK, CDH11, and others), plus associations between genomic changes and clinical parameters...
  55. ncbi Cell proliferation in the absence of E2F1-3
    Pamela L Wenzel
    Department of Molecular Virology, Immunology and Medical Genetics, Comprehensive Cancer Center, College of Medicine, The Ohio State University, Columbus, OH 43210, USA
    Dev Biol 351:35-45. 2011
    ..embryonic fibroblasts that concomitant loss of three E2F activators with overlapping functions (E2F1, E2F2, and E2F3) triggered the p53-p21(Cip1) response and caused cell cycle arrest...
  56. ncbi RB restricts DNA damage-initiated tumorigenesis through an LXCXE-dependent mechanism of transcriptional control
    Ryan J Bourgo
    Department of Cancer Biology, Kimmel Cancer Center, Thomas Jefferson University, Philadelphia, PA 19107, USA
    Mol Cell 43:663-72. 2011
    ..on this function of RB is unmasked after DNA damage, wherein LXCXE binding is essential for exerting control over E2F3 and suppressing cell-cycle progression in the presence of genotoxic stress...
  57. ncbi E2f1-3 are critical for myeloid development
    Prashant Trikha
    College of Medicine and Public Health, Ohio State University, Columbus, Ohio 43210, USA
    J Biol Chem 286:4783-95. 2011
    ..In current models of mammalian cell cycle control, E2f activators (E2f1, E2f2, and E2f3) are portrayed as the ultimate transcriptional effectors that commit cells to enter and progress through S phase...
  58. ncbi Prognostic impact of polymorphisms in the MYBL2 interacting genes in breast cancer
    Hong Shi
    Division of Molecular Genetic Epidemiology, German Cancer Research Center DKFZ, Im Neuenheimer Feld 580, 69120, Heidelberg, Germany
    Breast Cancer Res Treat 131:1039-47. 2012
    ..In this study, we investigated whether putative functional variants in genes regulating MYBL2 (E2F1, E2F3 and E2F4) or in genes, which are regulated by MYBL2 (BCL2, BIRC5, COL1A1, COL1A2, COL5A2, ERBB2, CLU, LIN9 and ..
  59. ncbi Proteomic and transcriptomic analyses of retinal pigment epithelial cells exposed to REF-1/TFPI-2
    Masahiko Shibuya
    Laboratory of Cellular and Molecular Biology, National Institute of Sensory Organs, National Hospital Organization Tokyo Medical Center, Tokyo, Japan
    Invest Ophthalmol Vis Sci 48:516-21. 2007
    ..The purpose of this study was to determine the genes and proteins of human RPE cells that are altered by exposure to TFPI-2...
  60. ncbi Rb is critical in a mammalian tissue stem cell population
    Pamela L Wenzel
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics, College of Medicine, The Ohio State University, Columbus, Ohio 43210, USA
    Genes Dev 21:85-97. 2007
    ..Loss of Rb resulted in an increase of E2f3 expression, and the combined ablation of Rb and E2f3 significantly suppressed Rb mutant phenotypes...
  61. ncbi A microRNA DNA methylation signature for human cancer metastasis
    Amaia Lujambio
    Cancer Epigenetics Laboratory, Spanish National Cancer Research Center, Melchor Fernandez Almagro 3, 28029 Madrid, Spain
    Proc Natl Acad Sci U S A 105:13556-61. 2008
    ..in xenograft models, with an associated down-regulation of the miRNA oncogenic target genes, such as C-MYC, E2F3, CDK6, and TGIF2...
  62. ncbi MicroRNA-125b suppresses the development of bladder cancer by targeting E2F3
    Li Huang
    Department of Urology, Sun Yat Sen Memorial Hospital, Sun Yat Sen University, Guangzhou, China
    Int J Cancer 128:1758-69. 2011
    ..b>E2F3, which was critical for G1/S transition and was overexpressed in most of poor-differentiated bladder cancers, was ..
  63. ncbi Rb-mediated neuronal differentiation through cell-cycle-independent regulation of E2f3a
    Danian Chen
    Genetics and Development Division, Toronto Western Research Institute, University Health Network, University of Toronto, Ontario, Canada
    PLoS Biol 5:e179. 2007
    ..Remarkably, however, Rb promotes SAC differentiation by inhibiting E2f3 activity...
  64. ncbi Susceptible genes and molecular pathways related to heavy ion irradiation in oral squamous cell carcinoma cells
    Kazuaki Fushimi
    Department of Clinical Molecular Biology, Graduate School of Medicine, Chiba University, Chiba, Japan
    Radiother Oncol 89:237-44. 2008
    ..The aim of the current study was to determine the difference of gene expression between heavy ion beams and X-rays in oral squamous cell carcinoma (OSCC)-derived cells...
  65. ncbi TGFbeta-mediated formation of pRb-E2F complexes in human myeloid leukemia cells
    Xiao Tang Hu
    School of Natural and Health Science, Barry University, 11300 Northeast Second Avenue, Miami Shores, FL 33161, USA
    Biochem Biophys Res Commun 369:277-80. 2008
    ..However, pRB-E2F1 and pRb-E2F3 complexes were found in proliferating cells but not in TGFbeta arrested G1 cells...
  66. ncbi miR-210 links hypoxia with cell cycle regulation and is deleted in human epithelial ovarian cancer
    Antonis Giannakakis
    Center for Research on Early Detection and Cure of Ovarian Cancer, University of Pennsylvania School of Medicine, Philadelphia, Pennsylvania 19104, USA
    Cancer Biol Ther 7:255-64. 2008
    ..Biocomputational analysis and in vitro assays demonstrated that e2f transcription factor 3 (e2f3), a key protein in cell cycle, is regulated by miR-210...
  67. ncbi [E2F1 upregulates endogenous XRCC1 expression]
    Juan Li
    Bejiing Youan Hospital Affiliated to Capital Medical University, Beijing 100069, China
    Zhonghua Shi Yan He Lin Chuang Bing Du Xue Za Zhi 22:186-8. 2008
    ..To investigate the regulatory effect and significance of transcription factor E2F1 on X-ray repair cross2 complementing 1 (XRCC1)...
  68. ncbi E2f3b plays an essential role in myogenic differentiation through isoform-specific gene regulation
    Patrik Asp
    New York University School of Medicine, New York University Cancer Institute, New York, New York 10016, USA
    Genes Dev 23:37-53. 2009
    ..The E2f3 locus encodes E2f3a and E2f3b proteins, and available data suggest that they regulate cell cycle-dependent gene ..
  69. ncbi MicroRNA-195 suppresses tumorigenicity and regulates G1/S transition of human hepatocellular carcinoma cells
    Teng Xu
    Key Laboratory of Gene Engineering of the Ministry of Education, State Key Laboratory of Biocontrol, School of Life Sciences, Guangzhou, PR China
    Hepatology 50:113-21. 2009
    ..Subsequent investigation characterized multiple G(1)/S transition-related molecules, including cyclin D1, CDK6, and E2F3, as direct targets of miR-195...
  70. ncbi Regulating A549 cells growth by ASO inhibiting miRNA expression
    Ping Yu Wang
    Department of Biochemistry and Molecular Biology, Institute of Medical Molecular Genetics, Binzhou Medical University, 264003 Yan Tai City, Shan Dong Province, People s Republic of China
    Mol Cell Biochem 339:163-71. 2010
    ..miR-125, miR-106, and miR-150 were the upstream factors, which could regulate the expression of BCL-2, E2F1, E2F3, RB1, and P53, respectively...
  71. ncbi Hypoxia inducible microRNA 210 attenuates keratinocyte proliferation and impairs closure in a murine model of ischemic wounds
    Sabyasachi Biswas
    Department of Surgery, Ohio State University Medical Center, Columbus, OH 43210, USA
    Proc Natl Acad Sci U S A 107:6976-81. 2010
    ..stabilization in ischemic wounds, where HIF-1alpha induced miR-210 expression that, in turn, silenced its target E2F3, which was markedly down-regulated in the wound-edge tissue of ischemic wounds...
  72. ncbi Widespread deregulation of microRNA expression in human prostate cancer
    M Ozen
    Department of Pathology, Baylor College of Medicine, Houston, TX, USA
    Oncogene 27:1788-93. 2008
    ..proteins have been previously shown to be increased in prostate cancer by immunohistochemistry, including RAS, E2F3, BCL-2 and MCL-1...
  73. ncbi Multiple E2F-induced microRNAs prevent replicative stress in response to mitogenic signaling
    María J Bueno
    Cell Division and Cancer Group, Spanish National Cancer Research Centre CNIO, Madrid, Spain
    Mol Cell Biol 30:2983-95. 2010
    ..Many of these miRNAs are specifically induced by E2F1 or E2F3 during the G(1)/S transition and are repressed in E2F1/3-knockout cells...
  74. ncbi Transcriptional regulation of subtilisin-like proprotein convertase PACE4 by E2F: possible role of E2F-mediated upregulation of PACE4 in tumor progression
    Keizo Yuasa
    Department of Biological Science and Technology, The University of Tokushima Graduate School, 2 1 Minamijosanjima, Tokushima 770 8506, Japan
    Gene 402:103-10. 2007
    ..Other E2F members, E2F2 and E2F3, also activated PACE4 expression, as in the case of E2F1...
  75. ncbi Measurement of blood E2F3 mRNA in prostate cancer by quantitative RT-PCR: a preliminary study
    Christodoulos P Pipinikas
    St George s University of London, Clinical Developmental Sciences, Medical Genetics, London, UK
    Biomarkers 12:541-57. 2007
    ..Overall efficiency of accurate diagnosis, when PSA levels are used alone, is less than 60%. E2F3 was evaluated as an alternative biomarker using patient blood samples...
  76. ncbi Genome-wide analyses of Nkx2-1 binding to transcriptional target genes uncover novel regulatory patterns conserved in lung development and tumors
    Jean Bosco Tagne
    Pulmonary Center, Boston University School of Medicine, Boston, Massachusetts, United States of America
    PLoS ONE 7:e29907. 2012
    ..New targets, validated in Nkx2-1 shRNA transduced cell lines, include E2f3, Cyclin B1, Cyclin B2, and c-Met...
  77. ncbi Nuclear overexpression of the E2F3 transcription factor in human lung cancer
    Colin S Cooper
    Section of Molecular Carcinogenesis, Male Urological Cancer Research Centre, Institute of Cancer Research, 15 Cotswold Road, Sutton, Surrey SM2 5NG, UK
    Lung Cancer 54:155-62. 2006
    The E2F3 transcription factor has an established role in controlling cell cycle progression...
  78. ncbi Regulation of cyclin D1 and p16(INK4A) is critical for growth arrest during mammary involution
    M Gadd
    Massachusetts General Hospital Cancer Center, Charlestown, Massachusetts 02129, USA
    Cancer Res 61:8811-9. 2001
    ..p16(INK4A) directly regulated the in vivo transition from E2F3 to E2F4 as the major E2F DNA binding activity, and its contribution to growth arrest was independent of cyclin D1...
  79. ncbi Deregulated E2F transcriptional activity in autonomously growing melanoma cells
    R Halaban
    Department of Dermatology, Yale University School of Medicine, New Haven, Connecticut 06520 8059, USA
    J Exp Med 191:1005-16. 2000
    ..In contrast, in melanoma cells, free E2F DNA binding activity (E2F2 and E2F4, to a lesser extent E2F1, E2F3, and occasionally E2F5), was constitutively maintained at high levels independently of external melanocyte mitogens...
  80. ncbi Combinatorial gene control involving E2F and E Box family members
    Paloma H Giangrande
    Department of Molecular Genetics and Microbiology, Howard Hughes Medical Institute, Duke University Medical Center, Durham, NC 27710, USA
    EMBO J 23:1336-47. 2004
    ..E2F target genes share a common promoter architecture and are also regulated by the combined action of TFE3 and E2F3. In contrast, the thymidine kinase (TK-1) promoter is also regulated by E2F3 but independent of TFE3...
  81. ncbi Expression of cell cycle/growth regulator genes in human hepatocellular carcinoma and adjacent normal liver tissues
    Lian Xin Liu
    Department of Surgery, The First Clinical College, Harbin Medical University, Nangang District, Harbin 150001, Heilongjiang Province, PR China
    Oncol Rep 10:1771-5. 2003
    ..The rapid and high-throughout method of profiling gene expression by cDNA array provides an overview of the key factors that may be involved in HCC. Some genes are reported for the first time in HCC...
  82. ncbi Regulation of FGF receptor-2 expression by transcription factor E2F-1
    Etsu Tashiro
    Department of Biosciences and Informatics, Faculty of Science and Technology, Keio University, Yokohama 223 8522, Japan
    Oncogene 22:5630-5. 2003
    ..Taken together, the results demonstrate that FGFR-2 is a new class of targets for E2F, and expression of mouse FGFR-2 in mid-to-late G1 phase would be mediated, at least in part, by the activation of a pRB/E2F pathway...
  83. ncbi E2F3 loss has opposing effects on different pRB-deficient tumors, resulting in suppression of pituitary tumors but metastasis of medullary thyroid carcinomas
    Ulrike Ziebold
    Center for Cancer Research, Massachusetts Institute of Technology, Cambridge, MA 02139, USA
    Mol Cell Biol 23:6542-52. 2003
    ..We have previously shown that E2F3 plays a critical role in mediating the mitogen-induced activation of E2F-responsive genes and contributes to both ..
  84. ncbi Specific regulation of E2F family members by cyclin-dependent kinases
    B D Dynlacht
    Department of Molecular and Cellular Biology, Harvard University, Cambridge, Massachusetts 02138, USA
    Mol Cell Biol 17:3867-75. 1997
    ..Thus, both enzymatic phosphorylation and stable physical interaction are necessary for the specific regulation of E2F family members by cyclin-dependent kinases...
  85. ncbi Regulation of E2F1 by BRCT domain-containing protein TopBP1
    Kang Liu
    Division of Hematology and Oncology, Department of Medicine, University of Alabama at Birmingham, Birmingham, Alabama 35294 3300, USA
    Mol Cell Biol 23:3287-304. 2003
    ..It was specific to E2F1 and was not observed in E2F2, E2F3, or E2F4. This interaction was induced by DNA damage and phosphorylation of E2F1 by ATM...
  86. ncbi Gene expression profiles of hepatoma cell line HLE
    Lian Xin Liu
    Department of Surgery, The First Clinical College of Harbin Medical University, No 23 Youzheng Street, Nangang District, Harbin 150001, China
    World J Gastroenterol 9:683-7. 2003
    ..To investigate the global gene expression of cancer related genes in hepatoma cell line HLE using Atlas Human Cancer Array membranes with 588 well-characterized human genes related with cancer and tumor biology...
  87. ncbi Expression patterns of the E2F family of transcription factors during mouse nervous system development
    L Dagnino
    Division of Immunology and Cancer Research, Hospital for Sick Children, Toronto, Ontario, Canada
    Mech Dev 66:13-25. 1997
    ..We conclude that individual E2F forms are differentially regulated during the development of distinct tissues, and especially during neuronal development...
  88. ncbi Changes in WT1 splicing are associated with a specific gene expression profile in Wilms' tumour
    Dominique Baudry
    INSERM U383, Hopital Necker Enfants Malades, Universite Rene Descartes, 75743 Paris Cedex 15, France
    Oncogene 21:5566-73. 2002
    ..Fourteen of 588 genes tested displayed specific up-regulation (CCND2, PCNA, N-MYC, E2F3, TOP2A, PAK1, DCC and PCDH2) or down-regulation (VEGF, IGFBP5, TIMP3, ARHB, C-FOS and CD9) in the pool of tumours ..
  89. ncbi Specificity of E2F1, E2F2, and E2F3 in mediating phenotypes induced by loss of Rb
    Harold I Saavedra
    Human Cancer Genetics Program, Department of Molecular Virology, Immunology and Medical Genetics and Department of Molecular Genetics, The Ohio State University, Columbus 43210, USA
    Cell Growth Differ 13:215-25. 2002
    ..Here, we report that E2F1, E2F2, and E2F3 make major individual contributions toward the in vivo phenotypic consequences of Rb deficiency...
  90. ncbi Differences in E2F subunit expression in quiescent and proliferating vascular smooth muscle cells
    Nobuya Fujita
    Division of Endocrinology and Metabolism, Department of Medicine, Jichi Medical School, Tochigi, Japan
    Am J Physiol Heart Circ Physiol 283:H204-12. 2002
    ..In contrast, both FBS and vasoconstrictive hormones drove transcription of the cdc6 gene by downregulating p130 and recruiting free E2F-3 in the latter, which underlies the progression of VSMC into S phase...
  91. ncbi Differential regulation of E2F transcription factors by p53 tumor suppressor protein
    Y N Vaishnav
    International Centre for Genetic Engineering and Biotechnology, New Delhi, India
    DNA Cell Biol 18:911-22. 1999
    ..The complex interplay between various positive and negative regulators of cell growth, such as E2F and p53 proteins, may be crucial in determining the ultimate outcome in terms of cell cycle arrest, cell growth, or apoptosis...
  92. ncbi E2F integrates cell cycle progression with DNA repair, replication, and G(2)/M checkpoints
    Bing Ren
    Whitehead Institute for Biomedical Research, Cambridge, Massachusetts 02142, USA
    Genes Dev 16:245-56. 2002
    ..Our data indicate that E2F directly links cell cycle progression with the coordinate regulation of genes essential for both the synthesis of DNA as well as its surveillance...
  93. ncbi E2f3 is critical for normal cellular proliferation
    P O Humbert
    Center for Cancer Research and Department of Biology, Massachusetts Institute of Technology, Cambridge, Massachusetts 02139 USA
    Genes Dev 14:690-703. 2000
    ..To establish the role of E2F3 in vivo, we generated an E2f3 mutant mouse strain...
  94. ncbi BRD7, a novel bromodomain gene, inhibits G1-S progression by transcriptionally regulating some important molecules involved in ras/MEK/ERK and Rb/E2F pathways
    Jie Zhou
    Cancer Research Institute, Xiang Ya School of Medicine, Central South University, Changsha, Hunan, People s Republic of China
    J Cell Physiol 200:89-98. 2004
    ..Moreover, we observed that BRD7 could regulate the promoter activity of E2F3, one of its targets...
  95. ncbi Deregulated E2F activity induces hyperplasia and senescence-like features in the mouse pituitary gland
    Eros Lazzerini Denchi
    Biotech Research and Innovation Center, Fruebjergvej 3, 2100 Copenhagen, Denmark
    Mol Cell Biol 25:2660-72. 2005
    ..E2F activity is sufficient to induce pituitary tumors, we generated transgenic mice expressing an inducible E2F3 protein in the intermediate lobe of the pituitary gland...
  96. ncbi Interplay between the retinoblastoma protein and LEK1 specifies stem cells toward the cardiac lineage
    Evangelia Papadimou
    CRBM, CNRS FRE 2593, Montpellier, France
    EMBO J 24:1750-61. 2005
    ..Rb-/- mice die at midgestation and mice lacking E2f1/E2f3, downstream components of the Rb-dependent transcriptional pathway, die of heart failure...
  97. ncbi HLXB9 activates IL6 in Hodgkin lymphoma cell lines and is regulated by PI3K signalling involving E2F3
    S Nagel
    DSMZ Deutsche Sammlung von Mikroorganismen und Zellkulturen, Department of Human and Animal Cell Cultures, Braunschweig, Germany
    Leukemia 19:841-6. 2005
    ..Downstream analysis of PI3K revealed that E2F3 may mediate activation of HLXB9...
  98. ncbi Compensation and specificity of function within the E2F family
    L J Kong
    Department of Molecular Genetics and Microbiology, Institute for Genome Sciences and Policy, Duke University Medical Center, Durham, NC 27710, USA
    Oncogene 26:321-7. 2007
    ..Indeed, in cells deleted of the E2F1 or E2F3 genes, there is an increase in the expression of the other family member...
  99. ncbi Induction of human metallothionein 1G promoter by VEGF and heavy metals: differential involvement of E2F and metal transcription factors
    Bharat Joshi
    Department of Interdisciplinary Oncology, H Lee Moffitt Cancer Center and Research Institute, 12902 Magnolia Drive, Tampa, FL 33612, USA
    Oncogene 24:2204-17. 2005
    ..Based on these findings, we conclude that induction of the hMT1G promoter by VEGF and heavy metals occurs through the utilization of different transcription factors...
  100. ncbi E2F-4 and E2F-5, two members of the E2F family, are expressed in the early phases of the cell cycle
    C Sardet
    Whitehead Institute for Biomedical Research, Cambridge, MA 02142
    Proc Natl Acad Sci U S A 92:2403-7. 1995
    ..These findings suggest that E2F-4 and E2F-5 may contribute to the regulation of early G1 events including the G0/G1 transition...
  101. ncbi Novel link between E2F and p53: proapoptotic cofactors of p53 are transcriptionally upregulated by E2F
    T Hershko
    Department of Molecular Cell Biology, The Weizmann Institute of Science, Rehovot 76100, Israel
    Cell Death Differ 12:377-83. 2005
    ..Overall, these data provide novel functional links between RB/E2F pathway and p53-induced apoptosis...

Research Grants62

  1. Regulation of the cell cycle by SCF and APC/C ubiquitin ligases
    Michele Pagano; Fiscal Year: 2009
    ..we will characterize the mechanism, regulation and biological function of the degradation of one of them, namely E2F3, a protein intimately involved in the control of the cell cycle (Aim 1)...
  2. E2F-mediated Control of Vascular Growth and Remodeling
    Bruce Sullenger; Fiscal Year: 2006
    ..The first subclass, containing E2F1, E2F2 and E2F3, are transcriptional activators that induce quiescent cells to proliferate...
  3. E2F3: a suppressor of centrosome amplification
    HAROLD SAAVEDRA; Fiscal Year: 2007
    ..One of the central components of the Rb/E2F pathway is the E2F3 transcription factor, which plays a key role in cell cycle progression...
  4. Tumor Suppressor and Oncogenic Pathways in the Placenta
    Lizhao Wu; Fiscal Year: 2007
    ..3. To examine the genetic regulatory networks employed by Rb in the placenta. E2F1, E2F2, E2F3, and Id2 can mediate Rb function in vivo, and concomitant genetic deletion of Rb and either of E2F1, E2F3, or Id2 ..
  5. Retinoblastoma during placental & embryonic development
    Michael Weinstein; Fiscal Year: 2006
    ..Specific Aim 3. Examine the genetic regulatory networks employed by Rb in the placenta. The bHILH factors E2F3, and 1d2 both exert functions in the placenta, and genetic deletion of either prevents the occurrence of many ..
  6. E2F3 and embryonic development
    Gustavo Leone; Fiscal Year: 2007
    ..Among E2F family members, E2F3 has emerged as a key Rb-regulated activity that controls the proliferation of normal and tumor cells...
  7. Dissecting E2f3's role in tumorigenesis
    JACQUELINE LEES; Fiscal Year: 2007
    ..This proposal focuses on one member of the E2f family, E2f3, which is a component of both the pRB and p53 networks and whose amplification has been linked to the development ..
  8. Dissecting E2f3's role in tumorigenesis
    JACQUELINE LEES; Fiscal Year: 2009
    ..This proposal focuses on one member of the E2f family, E2f3, which is a component of both the pRB and p53 networks and whose amplification has been linked to the development ..
  9. Dissecting E2f3's role in tumorigenesis
    Jacqueline A Lees; Fiscal Year: 2010
    ..This proposal focuses on one member of the E2f family, E2f3, which is a component of both the pRB and p53 networks and whose amplification has been linked to the development ..
  10. E2F3 GENE LOCUS IN THE CONTROL OF CELL PROLIFERATION
    Gustavo Leone; Fiscal Year: 2005
    ..Our recent findings have pointed to a role for the E2F3 gene locus as a particularly important regulator of the cell cycle by encoding two independent but overlapping ..
  11. E2F AND THE CONTROL OF APOPTOSIS
    Gustavo Leone; Fiscal Year: 2003
    ..The proposed studies will be directed at understanding the role and the mechanism of action of E2F1, E2F2 and E2F3 in the regulation of cell death, and how other signal transduction pathways important for normal cellular ..